Tempus AI remains a resilient healthcare AI leader, with proprietary data driving traction and a clear buy opportunity amid recent volatility. TEM reported preliminary 2025 revenue of ~$1.27B (+30% ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Hosted on MSN
Tempus AI, Inc. (TEM) strengthens precision medicine with new tools, partnerships, and growth milestones
Tempus AI, Inc. (NASDAQ:TEM) is one of the best Nancy Pelosi Stocks to buy in 2026. On January 27, Tempus AI, Inc. (NASDAQ:TEM) confirmed that its Immune Profile Score Test accurately predicts patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results